Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
The Journal of Infectious Diseases|August 15, 2022
Expected Impact of Universal Immunization With Nirsevimab Against RSV-Related Outcomes and Costs Among All US Infants in Their First RSV Season: A Static ModelAlexia Kieffer, Matthieu Beuvelet, Aditya Sardesai, et al.
Virology Journal|January 29, 2014
Determinants of individuals' risks to 2009 pandemic influenza virus infection at household level amongst Djibouti city residents--a CoPanFlu cross-sectional studyFred Andayi, Pascal Crepey, Alexia Kieffer, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 28, 2022
Cost-Effectiveness of Respiratory Syncytial Virus Preventive Interventions in Children: A Model Comparison StudyXiao Li, David Hodgson, Julien Flaig, et al.
Atherosclerosis|January 15, 2008
Correlates of LDL-cholesterol goal attainment in patients under lipid lowering therapyLaurent Laforest, Philippe Moulin, Thierry Souchet, et al.
Plos One|January 3, 2018
Protecting children from rabies with education and pre-exposure prophylaxis: A school-based campaign in El Nido, Palawan, PhilippinesRaffy Deray, Cesar Rivera, Shiela Gripon, et al.
The Pediatric Infectious Disease Journal|March 13, 2015
Modeling the long-term persistence of hepatitis A antibody after a two-dose vaccination schedule in Argentinean childrenEduardo L López, María Marta Contrini, Alicia Mistchenko, et al.
Plos Neglected Tropical Diseases|December 16, 2014
A sero-epidemiological study of arboviral fevers in Djibouti, Horn of AfricaFred Andayi, Remi N Charrel, Alexia Kieffer, et al.
Global & Regional Health Technology Assessment|February 3, 2025
Economic and clinical burden associated with respiratory syncytial virus and impact of universal immunization with nirsevimab in ItalyAndrea Marcellusi, Chiara Bini, Barbara Muzii, et al.
Plos One|May 3, 2013
2009 A(H1N1) seroconversion rates and risk factors among the general population in Vientiane Capital, LaosAlexia Kieffer, Phimpha Paboriboune, Pascal Crépey, et al.
BMC Infectious Diseases|September 6, 2024
Modelling the potential clinical and economic impact of universal immunisation with nirsevimab versus standard of practice for protecting all neonates and infants in their first respiratory syncytial virus season in SpainRuth Gil-Prieto, Jaime Jesus Pérez, Georgina Drago, et al.
Pageof 3